Cargando…
Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277078/ https://www.ncbi.nlm.nih.gov/pubmed/37328273 http://dx.doi.org/10.1136/bmjdrc-2022-003300 |
| _version_ | 1785060213997436928 |
|---|---|
| author | Bain, Stephen C Carstensen, Bendix Hyveled, Liselotte Seremetis, Stephanie Flindt Kreiner, Frederik Amadid, Hanan Clark, Alice |
| author_facet | Bain, Stephen C Carstensen, Bendix Hyveled, Liselotte Seremetis, Stephanie Flindt Kreiner, Frederik Amadid, Hanan Clark, Alice |
| author_sort | Bain, Stephen C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10277078 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102770782023-06-19 Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study Bain, Stephen C Carstensen, Bendix Hyveled, Liselotte Seremetis, Stephanie Flindt Kreiner, Frederik Amadid, Hanan Clark, Alice BMJ Open Diabetes Res Care Letter BMJ Publishing Group 2023-06-16 /pmc/articles/PMC10277078/ /pubmed/37328273 http://dx.doi.org/10.1136/bmjdrc-2022-003300 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Bain, Stephen C Carstensen, Bendix Hyveled, Liselotte Seremetis, Stephanie Flindt Kreiner, Frederik Amadid, Hanan Clark, Alice Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title | Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title_full | Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title_fullStr | Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title_full_unstemmed | Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title_short | Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| title_sort | glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277078/ https://www.ncbi.nlm.nih.gov/pubmed/37328273 http://dx.doi.org/10.1136/bmjdrc-2022-003300 |
| work_keys_str_mv | AT bainstephenc glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT carstensenbendix glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT hyveledliselotte glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT seremetisstephanie glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT flindtkreinerfrederik glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT amadidhanan glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy AT clarkalice glucagonlikepeptide1receptoragonistuseisassociatedwithlowerbloodferritinlevelsinpeoplewithtype2diabetesandhemochromatosisanationwideregisterbasedstudy |